Notice of Request for Information by the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 32335-32336 [2016-12043]
Download as PDF
<![CDATA[
32335
Federal Register / Vol. 81, No. 99 / Monday, May 23, 2016 / Notices
NHANES, including questions about
food security and nutrition program
participation, dietary supplement use,
and weight history/self-image/related
behavior.
In 2017–2018, we also plan to
conduct a Dietary Supplement Imaging
pilot study, as well as implement multimode screening and electronic consent
procedures in NHANES. The consent for
birth certificate linkage that had been
included in previous NHANES will be
dropped from NHANES 2017–2018.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Individuals
Individuals
Individuals
Individuals
Individuals
in
in
in
in
in
households
households
households
households
households
Number of
responses per
respondent
Number of
respondents
Form name
Average
burden per response (in
hours)
Total burden
hours
14,410
1,404
2,000
1,200
2,880
1
1
1
1
1
2.5
30/60
30/60
25
10/60
36,025
702
1,000
30,000
480
2,520
1
10/60
420
2,160
1
10/60
360
1,800
1
10/60
300
5,000
1
20/60
1,667
Individuals in households
NHANES Questionnaire ......................................
Blood Pressure Methodology Study Phase 1 .....
Blood Pressure Methodology Study Phase 2 .....
Ambulatory Blood Pressure Pilot Study ..............
Oral HPV rinse Follow-up Study 6 months (estimated 80% of original sample of 3600).
Oral HPV rinse Follow-up Study 12 Months (estimated 70% of original sample).
Oral HPV rinse Follow-up Study 18 months (estimated 60% of original sample).
Oral HPV rinse Follow-up Study 24 Months (estimated 50% of original sample).
Flexible Consumer Behavior Survey Phone Follow-Up.
Special Studies ....................................................
3,500
1
3
10,500
Total ........................
..............................................................................
........................
........................
........................
81,454
Individuals in households
Individuals in households
Individuals in households
Individuals in households
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–12009 Filed 5–20–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Request for Information by
the Presidential Advisory Council on
Combating Antibiotic-Resistant
Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
sradovich on DSK3TPTVN1PROD with NOTICES
Comments must be received by
11:59 p.m. on June 22, 2016 to be
considered.
DATES:
VerDate Sep<11>2014
18:25 May 20, 2016
Jkt 238001
Individuals are encouraged
to submit their responses through one of
the following methods. Utilization of
the online form available on
www.hhs.gov/ash/carb is the preferred
method of submission. Should you
choose to send in your responses via
email, please be sure to include the
question number(s) in the subject line.
Do not include in your response
information of a confidential nature,
such as sensitive personal information
or proprietary information. Responses to
this notice are not offers and cannot be
accepted by the federal government to
form a binding contract or issue a grant.
Please be aware that your comments
will not affirmatively be posted
ADDRESSES:
The Presidential Advisory
Council on Combating AntibioticResistant Bacteria (Advisory Council)
requests information from the general
public and stakeholders related to
efforts and strategies to combat
antibiotic-resistance. In the process of
developing their report, Initial
Assessments of the National Action
Plan for Combating Antibiotic-Resistant
Bacteria, the Advisory Council followed
the framework of the National Action
Plan for Combating Antibiotic Resistant
Bacteria (Action Plan) to hear about a
wide range of ongoing and planned
activities by the federal government,
SUMMARY:
including some stakeholders/sectors
relevant to this overall effort. This
Request for Information (RFI) offers the
opportunity for interested individuals,
organizations, associations, industries,
and others, to provide their feedback.
Responses to the questions must be
received by 11:59 p.m. on June 22, 2016
to be considered. The questions are also
available through an online form on the
Advisory Council Web page at
www.hhs.gov/ash/carb. Individuals who
wish to send in their responses via
email should send an email to CARB@
hhs.gov, indicating the question
number(s) for which they are
responding.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
publicly, however they may be made
available to the public, in part or in full,
subject to applicable laws and
regulations.
• Online Form: www.hhs.gov/ash/
carb. Online submissions will receive
an automatic confirmation
acknowledging receipt of your response,
but will not receive individualized
feedback on any suggestions.
• Email: CARB@hhs.gov. Please
indicate the question number(s) in the
subject line of your email. Email
submissions will receive an electronic
confirmation acknowledging receipt of
your response, but will not receive
individualized feedback on any
suggestions.
SUPPLEMENTARY INFORMATION: Under
Executive Order 13676, dated
September 18, 2014, authority was given
to the Secretary of Health and Human
Services (HHS) to establish the Advisory
Council, in consultation with the
Secretaries of Defense and Agriculture.
Activities of the Advisory Council are
governed by the provisions of Public
Law 92–463, as amended (5 U.S.C.
App.), which sets forth standards for the
formation and use of federal advisory
committees.
The Advisory Council will provide
advice, information, and
recommendations to the Secretary of
HHS regarding programs and policies
intended to support and evaluate the
implementation of Executive Order
13676, including the National Strategy
for Combating Antibiotic-Resistant
E:\FR\FM\23MYN1.SGM
23MYN1
sradovich on DSK3TPTVN1PROD with NOTICES
32336
Federal Register / Vol. 81, No. 99 / Monday, May 23, 2016 / Notices
Bacteria and the Action Plan. The
Advisory Council shall function solely
for advisory purposes.
In carrying out its mission, the
Advisory Council will provide advice,
information, and recommendations to
the Secretary regarding programs and
policies intended to preserve the
effectiveness of antibiotics by
optimizing their use; advance research
to develop improved methods for
combating antibiotic resistance and
conducting antibiotic stewardship;
strengthen surveillance of antibioticresistant bacterial infections; prevent
the transmission of antibiotic-resistant
bacterial infections; advance the
development of rapid point-of-care and
agricultural diagnostics; further research
on new treatments for bacterial
infections; develop alternatives to
antibiotics for agricultural purposes;
maximize the dissemination of up-todate information on the appropriate and
proper use of antibiotics to the general
public and human and animal
healthcare providers; and improve
international coordination of efforts to
combat antibiotic resistance. In response
to their mission, the Advisory Council
recently released their first report,
Initial Assessments of the National
Action Plan for Combating AntibioticResistant Bacteria, at their second
public meeting held on March 30–31,
2016, in Washington, DC.
Background: In the process of
developing their report, the Advisory
Council followed the framework of the
Action Plan to hear about a wide range
of ongoing and planned activities by the
federal government, including some
stakeholders/sectors relevant to this
overall effort. Acknowledging that there
are others who the Advisory Council
would like to hear from, they are
seeking that information through this
RFI. The purpose of the questions posed
in this RFI is to gain additional
information from the public on the
subject matter in several areas addressed
in the Action Plan. The responses
gathered from the RFI will be reviewed
by the members of the Advisory Council
and will be taken into consideration as
they move forward with their activities.
The responses provided are for the
Advisory Council’s informational
purposes only. Response to this RFI is
voluntary. Responders are free to
address any or all of the questions
below.
Request for Information: To solicit
additional information from the public,
including individuals, organizations,
associations, and industries involved in
combating antibiotic-resistance, the
Advisory Council seeks responses on
the following requests for information:
VerDate Sep<11>2014
18:25 May 20, 2016
Jkt 238001
1. Describe how organizations are
influencing curricula regarding primary
prevention (antibiotic stewardship,
infection prevention, and control).
Please include information about
certification examinations,
requirements, and continuing
education, if relevant.
2. Describe how healthcare
organizations can best: (a) Educate and
provide feedback to providers in clinics/
facilities about infectious diseases
diagnostic testing, optimal antibiotic
prescribing, and infection prevention;
where relevant, please include
information about what incentives and
disincentives these organizations have
in place with the goal of improving
antibiotic prescribing (e.g., using
clinical decision support) and prevent
spread of resistant infections; and, (b)
encourage and/or incentivize providers
to report antibiotic use and resistance
data for all patient populations.
3. Please provide examples of
successful behavior change models that
can be applied to preventive strategies,
such as infection control and antibiotic
stewardship.
4. Please provide information on the
best ways to collect data on antibiotic
use [and resistance] in animal
agriculture through public-private
collaborations. Your response can
include information on the types of data
to be collected, including the method of
collection, and the metrics for reporting
the data. If helpful, please cite sample
models as examples to depict your
answer.
5. Please provide information on the
different resources that exist to promote
the understanding of how antibiotics are
being used in humans and animals in
different parts of the world. Your
response can include information on the
types of support to connect with such
resources, as appropriate (examples
include public-private partnerships,
strategic resourcing, or other means).
More information can be found at
www.hhs.gov/ash/carb.
Dated: May 18, 2016.
Bruce Gellin,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Deputy Assistant Secretary
for Health.
[FR Doc. 2016–12043 Filed 5–20–16; 8:45 am]
BILLING CODE 4150–44–P
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurotransporters, Receptors,
and Calcium Signaling Study Section.
Date: June 16–17, 2016.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Westin Crystal City, 1800 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Peter B. Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Molecular
and Cellular Endocrinology Study Section.
Date: June 16–17, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westgate Hotel, 1055 2nd Ave.,
San Diego, CA 92101.
Contact Person: John Bleasdale, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892, 301–435–
4514, bleasdaleje@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Gene and Drug Delivery Systems
Study Section.
Date: June 22–23, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Amy L. Rubinstein, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152,
MSC 7844, Bethesda, MD 20892, 301–408–
9754, rubinsteinal@csr.nih.gov.
E:\FR\FM\23MYN1.SGM
23MYN1
]]>Agencies
[Federal Register Volume 81, Number 99 (Monday, May 23, 2016)]
[Notices]
[Pages 32335-32336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12043]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Notice of Request for Information by the Presidential Advisory
Council on Combating Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria (Advisory Council) requests information from the
general public and stakeholders related to efforts and strategies to
combat antibiotic-resistance. In the process of developing their
report, Initial Assessments of the National Action Plan for Combating
Antibiotic-Resistant Bacteria, the Advisory Council followed the
framework of the National Action Plan for Combating Antibiotic
Resistant Bacteria (Action Plan) to hear about a wide range of ongoing
and planned activities by the federal government, including some
stakeholders/sectors relevant to this overall effort. This Request for
Information (RFI) offers the opportunity for interested individuals,
organizations, associations, industries, and others, to provide their
feedback. Responses to the questions must be received by 11:59 p.m. on
June 22, 2016 to be considered. The questions are also available
through an online form on the Advisory Council Web page at www.hhs.gov/ash/carb. Individuals who wish to send in their responses via email
should send an email to CARB@hhs.gov, indicating the question number(s)
for which they are responding.
DATES: Comments must be received by 11:59 p.m. on June 22, 2016 to be
considered.
ADDRESSES: Individuals are encouraged to submit their responses through
one of the following methods. Utilization of the online form available
on www.hhs.gov/ash/carb is the preferred method of submission. Should
you choose to send in your responses via email, please be sure to
include the question number(s) in the subject line. Do not include in
your response information of a confidential nature, such as sensitive
personal information or proprietary information. Responses to this
notice are not offers and cannot be accepted by the federal government
to form a binding contract or issue a grant. Please be aware that your
comments will not affirmatively be posted publicly, however they may be
made available to the public, in part or in full, subject to applicable
laws and regulations.
Online Form: www.hhs.gov/ash/carb. Online submissions will
receive an automatic confirmation acknowledging receipt of your
response, but will not receive individualized feedback on any
suggestions.
Email: CARB@hhs.gov. Please indicate the question
number(s) in the subject line of your email. Email submissions will
receive an electronic confirmation acknowledging receipt of your
response, but will not receive individualized feedback on any
suggestions.
SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September
18, 2014, authority was given to the Secretary of Health and Human
Services (HHS) to establish the Advisory Council, in consultation with
the Secretaries of Defense and Agriculture. Activities of the Advisory
Council are governed by the provisions of Public Law 92-463, as amended
(5 U.S.C. App.), which sets forth standards for the formation and use
of federal advisory committees.
The Advisory Council will provide advice, information, and
recommendations to the Secretary of HHS regarding programs and policies
intended to support and evaluate the implementation of Executive Order
13676, including the National Strategy for Combating Antibiotic-
Resistant
[[Page 32336]]
Bacteria and the Action Plan. The Advisory Council shall function
solely for advisory purposes.
In carrying out its mission, the Advisory Council will provide
advice, information, and recommendations to the Secretary regarding
programs and policies intended to preserve the effectiveness of
antibiotics by optimizing their use; advance research to develop
improved methods for combating antibiotic resistance and conducting
antibiotic stewardship; strengthen surveillance of antibiotic-resistant
bacterial infections; prevent the transmission of antibiotic-resistant
bacterial infections; advance the development of rapid point-of-care
and agricultural diagnostics; further research on new treatments for
bacterial infections; develop alternatives to antibiotics for
agricultural purposes; maximize the dissemination of up-to-date
information on the appropriate and proper use of antibiotics to the
general public and human and animal healthcare providers; and improve
international coordination of efforts to combat antibiotic resistance.
In response to their mission, the Advisory Council recently released
their first report, Initial Assessments of the National Action Plan for
Combating Antibiotic-Resistant Bacteria, at their second public meeting
held on March 30-31, 2016, in Washington, DC.
Background: In the process of developing their report, the Advisory
Council followed the framework of the Action Plan to hear about a wide
range of ongoing and planned activities by the federal government,
including some stakeholders/sectors relevant to this overall effort.
Acknowledging that there are others who the Advisory Council would like
to hear from, they are seeking that information through this RFI. The
purpose of the questions posed in this RFI is to gain additional
information from the public on the subject matter in several areas
addressed in the Action Plan. The responses gathered from the RFI will
be reviewed by the members of the Advisory Council and will be taken
into consideration as they move forward with their activities. The
responses provided are for the Advisory Council's informational
purposes only. Response to this RFI is voluntary. Responders are free
to address any or all of the questions below.
Request for Information: To solicit additional information from the
public, including individuals, organizations, associations, and
industries involved in combating antibiotic-resistance, the Advisory
Council seeks responses on the following requests for information:
1. Describe how organizations are influencing curricula regarding
primary prevention (antibiotic stewardship, infection prevention, and
control). Please include information about certification examinations,
requirements, and continuing education, if relevant.
2. Describe how healthcare organizations can best: (a) Educate and
provide feedback to providers in clinics/facilities about infectious
diseases diagnostic testing, optimal antibiotic prescribing, and
infection prevention; where relevant, please include information about
what incentives and disincentives these organizations have in place
with the goal of improving antibiotic prescribing (e.g., using clinical
decision support) and prevent spread of resistant infections; and, (b)
encourage and/or incentivize providers to report antibiotic use and
resistance data for all patient populations.
3. Please provide examples of successful behavior change models
that can be applied to preventive strategies, such as infection control
and antibiotic stewardship.
4. Please provide information on the best ways to collect data on
antibiotic use [and resistance] in animal agriculture through public-
private collaborations. Your response can include information on the
types of data to be collected, including the method of collection, and
the metrics for reporting the data. If helpful, please cite sample
models as examples to depict your answer.
5. Please provide information on the different resources that exist
to promote the understanding of how antibiotics are being used in
humans and animals in different parts of the world. Your response can
include information on the types of support to connect with such
resources, as appropriate (examples include public-private
partnerships, strategic resourcing, or other means).
More information can be found at www.hhs.gov/ash/carb.
Dated: May 18, 2016.
Bruce Gellin,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Deputy Assistant Secretary for Health.
[FR Doc. 2016-12043 Filed 5-20-16; 8:45 am]
BILLING CODE 4150-44-P
